![](/img/cover-not-exists.png)
FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis Who HAD an Inadequate Response to Methotrexate Therapy: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study
Smolen, J.S., Weinblatt, M.E., van der Heijde, D., Rigby, W.F., van Vollenhoven, R., Bingham, C.O., Veenhuizen, M., Gill, A., Zou, H., Komocsar, W., Berclaz, P.-Y., Ortmann, R., Lee, C.Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-eular.1535
Date:
June, 2014
File:
PDF, 73 KB
english, 2014